| Hang Seng Index | 24.580 HKD | +0.220 | +0.903% | 191.10M | 4.68B | 24.562 (+0.075%) HKD as at 2025/07/03 | | |
| Hang Seng TECH Index | 5.205 HKD | +0.070 | +1.363% | 729.67M | 3.79B | 5.145 (+1.176%) HKD as at 2025/07/03 | | |
| Hang Seng China Enterprises | 88.860 HKD | +0.840 | +0.954% | 32.04M | 2.84B | 89.115 (-0.286%) HKD as at 2025/07/02 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.100 HKD | +0.140 | +2.823% | 96.60M | 488.75M | 4.983 (+2.358%) HKD as at 2025/07/03 | | |
| CSI Hong Kong Dividend | 36.680 HKD | +0.260 | +0.714% | 10.71M | 392.88M | 36.581 (+0.272%) HKD as at 2025/07/03 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.722 HKD | -0.054 | -3.041% | 191.99M | 333.20M | 1.768 (-2.624%) HKD as at 2025/07/03 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.198 HKD | -0.038 | -1.699% | 71.95M | 158.81M | 2.206 (-0.367%) HKD as at 2025/07/03 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.305 HKD | +0.075 | +1.434% | 24.87M | 131.46M | 5.297 (+0.157%) HKD as at 2025/07/03 | | |
| Hang Seng TECH Index | 11.170 HKD | +0.160 | +1.453% | 7.68M | 85.23M | 11.099 (+0.640%) HKD as at 2025/07/02 | | |
| Hang Seng China Enterprises | 10.550 HKD | +0.070 | +0.668% | 5.18M | 54.61M | 10.501 (+0.470%) HKD as at 2025/07/02 | | |
| FTSE China A50 | 14.610 HKD | +0.050 | +0.343% | 3.39M | 49.45M | 14.405 (+1.427%) HKD as at 2025/07/02 | | |
| Hang Seng TECH Index | 5.290 HKD | +0.085 | +1.633% | 9.04M | 47.57M | 5.257 (+0.622%) HKD as at 2025/07/02 | | |
| London Gold Fixing Price | 2,411.000 HKD | +21.000 | +0.879% | 8.23K | 19.83M | N/A | | |
| FTSE US Treasury 20+ Years Index | 68.400 HKD | -0.340 | -0.495% | 209.85K | 14.34M | 69.288 (-1.282%) HKD as at 2025/07/02 | | |
| CSI 300 | 45.480 HKD | +0.320 | +0.709% | 273.52K | 12.41M | 45.310 (+0.375%) HKD as at 2025/07/03 | | |
| Hang Seng High Dividend Yield | 28.700 HKD | 0.000 | 0.000% | 358.72K | 10.30M | 28.593 (+0.376%) HKD as at 2025/07/02 | | |
| FTSE China A50 | 13.600 HKD | +0.060 | +0.443% | 466.06K | 6.32M | 13.513 (+0.645%) HKD as at 2025/07/03 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 13.750 HKD | -0.050 | -0.362% | 396.20K | 5.48M | 14.001 (-1.791%) HKD as at 2025/07/03 | | |
| CSI 300 | 41.500 CNY | +0.200 | +0.484% | 131.80K | 5.45M | 41.336 (+0.396%) CNY as at 2025/07/03 | | |
| Hang Seng Index | 24.660 HKD | +0.240 | +0.983% | 215.50K | 5.31M | 24.630 (+0.121%) HKD as at 2025/07/03 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 4.014 HKD | +0.010 | +0.250% | 1.27M | 5.09M | 4.041 (-0.673%) HKD as at 2025/07/02 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.280 HKD | +0.054 | +1.674% | 1.35M | 4.40M | 3.248 (+1.001%) HKD as at 2025/07/03 | | |
| FTSE China A50 | 12.420 CNY | +0.030 | +0.242% | 345.40K | 4.29M | 12.325 (+0.768%) CNY as at 2025/07/03 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 16.950 HKD | +0.320 | +1.924% | 249.00K | 4.22M | 17.144 (-1.132%) HKD as at 2025/07/02 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 13.380 HKD | -0.130 | -0.962% | 261.73K | 3.49M | 13.535 (-1.145%) HKD as at 2025/07/03 | | |
| Short-term deposits and high quality money market investments | 9,354.250 HKD | +1.050 | +0.011% | 282.00 | 2.64M | 9,340.813 (+0.144%) HKD as at 2025/07/02 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 3.734 HKD | -0.040 | -1.060% | 629.40K | 2.35M | 3.744 (-0.278%) HKD as at 2025/07/03 | | |
| CME Bitcoin Futures | 36.720 HKD | -0.480 | -1.290% | 62.74K | 2.30M | 37.496 (-2.070%) HKD as at 2025/07/02 | | |
| MSCI China | 24.520 HKD | +0.240 | +0.988% | 86.05K | 2.10M | 24.469 (+0.210%) HKD as at 2025/07/02 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng China Enterprises | 1.694 HKD | -0.042 | -2.419% | 1.20M | 2.05M | 1.716 (-1.271%) HKD as at 2025/07/03 | | |